Paradigm Biocapital Advisors LP Q4 2022 Filing
Filed February 14, 2023
Portfolio Value
$851.9T
Holdings
23
Report Date
Q4 2022
Filing Type
13F-HR
All Holdings (23 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | INCYINCYTE CORP | 852,830 | $68.5T | 8.04% | |
| 2 | BIIBBIOGEN INC | 238,772 | $66.1T | 7.76% | |
| 3 | MRTXEURMIRATI THERAPEUTICS INC | 1,267,970 | $57.5T | 6.74% | |
| 4 | HZNPHORIZON THERAPEUTICS PUB L | 477,585 | $54.3T | 6.38% | |
| 5 | LEGNLEGEND BIOTECH CORP | 1,054,870 | $52.7T | 6.18% | |
| 6 | VRDNVIRIDIAN THERAPEUTICS INC | 1,751,167 | $51.2T | 6.00% | |
| 7 | SNDXSYNDAX PHARMACEUTICALS INC | 1,954,512 | $49.7T | 5.84% | |
| 8 | IMCRIMMUNOCORE HLDGS PLC | 857,925 | $49.0T | 5.75% | |
| 9 | ASNDASCENDIS PHARMA A/S | 352,808 | $43.1T | 5.06% | |
| 10 | VORVOR BIOPHARMA INC | 6,442,825 | $42.8T | 5.03% | |
| 11 | UTHUNITED THERAPEUTICS CORP DEL | 148,892 | $41.4T | 4.86% | |
| 12 | SGENUSDSEAGEN INC | 286,288 | $36.8T | 4.32% | |
| 13 | BCYCBICYCLE THERAPEUTICS PLC | 1,233,280 | $36.5T | 4.29% | |
| 14 | ARGXARGENX SE | 89,556 | $33.9T | 3.98% | |
| 15 | AKROAKERO THERAPEUTICS INC | 604,544 | $33.1T | 3.89% | |
| 16 | ACLXARCELLX INC | 882,101 | $27.3T | 3.21% | |
| 17 | KRTXKARUNA THERAPEUTICS INC | 106,210 | $20.9T | 2.45% | |
| 18 | ARVNARVINAS INC | 599,599 | $20.5T | 2.41% | |
| 19 | NVLSEURALPINE IMMUNE SCIENCES INC | 2,317,634 | $17.0T | 2.00% | |
| 20 | CRNXCRINETICS PHARMACEUTICALS IN | 890,105 | $16.3T | 1.91% | |
| 21 | ZLABZAI LAB LTD | 515,274 | $15.8T | 1.86% | |
| 22 | PSTXUSDPOSEIDA THERAPEUTICS INC | 2,434,816 | $12.9T | 1.51% | |
| 23 | PRTAPROTHENA CORP PLC | 75,000 | $4.5T | 0.53% |